Clinical outcome and olanzapine plasma levels in acute schizophrenia

European Psychiatry

Volumn 20, Issue 1, 2005, Pages 55-60

  Mauri, M C ^a   Steinhilber, C P C ^b   Marino, R ^b   Invernizzi, E ^b   Fiorentini, A ^a   Cerveri, G ^a   Baldi, M L ^c   Barale, F ^b  

^a MAGGIORE HOSPITAL   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

^c FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

Acute schizophrenia; Olanzapine; Plasma levels

Indexed keywords

OLANZAPINE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE EXACERBATION; DRUG BLOOD LEVEL; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OPEN STUDY; PRIORITY JOURNAL; RATING SCALE; SCHIZOPHRENIA; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; TIME FACTORS; TREATMENT OUTCOME;

EID: 11844257017     PISSN: 09249338     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eurpsy.2004.09.009     Document Type: Article

References (30)

1. A.C. Altamura Novel antipsychotics and the problem of clinical stabilization in schizophrenia: are they "stabilizer" rather than typical compounds? Int. Clin. Psychopharmacol. 11 1996 153 155
2. American Psychiatric Association DSM-IV Diagnostic and Statistical Manual of Mental Disorders. 4th ed 1994 APA Washington, DC
3. J.M. Azorin Acute phase of schizophrenia: impact of atypical antipsychotics Int. Clin. Psychopharmacol. 15 Suppl 4 2000 5 9
4. C.M. Beasley, G. Tollefson, P. Tran, W. Satterlee, T. Sanger, and S. Hamilton Olanzapine versus placebo and haloperidol: acute phase results of the North American double-blind olanzapine trial Neuropsychopharmacol 14 Suppl 2 1996 111 123
5. M. Bernardo, E. Parellada, F. Lomena, A.M. Catafau, M. Font, and J.C. Gomez Double-blind olanzapine versus haloperidol D2 dopamine receptor blockade in schizophrenic patients: a baseline-endpoint Psychiatry Res. 107 Suppl 2 2001 87 97
6. M. Birchwood, R. Mason, F. MacMillan, and J. Healy Depression, demoralization and control over psychotic illness: a comparison of depressed and non-depressed patients with a chronic psychosis Psychol. Med. 23 Suppl 2 1993 387 395
7. F.P. Bymaster, K. Rasmussen, D.O. Calligaro, D.L. Nelson, N.W. De Lapp, and D.T. Wong In vitro and in vivo biochemistry of olanzapine: a novel, atypical antipsychotic drug J. Clin. Psychiatry 58 Suppl 10 1997 28 36
8. J.T. Callagan, R.F. Bergstrom, and L.R. Ptak Olanzapine. Pharmacokinetic and pharmacodynamic profile Clin. Pharmacokinet. 37 Suppl 3 1999 77 193
9. J.M. Davis, and N. Chen The effects of olanzapine on the 5 dimensions of schizophrenia derived by factors analysis: combined results of the North American and international trials J. Clin. Psychiatry 62 Suppl 10 2001 757 771
10. C.L. De Vane Markowitz JS Antipsychotics R.H. Levy Metabolic Drug Interactions 2000 Lippincott Williams & Wilkins Philadelphia 245 257
11. D. Feifel, C.Y. Moutier, and W. Perry Safety and tolerability of a rapidly escalating dose-loading regimen for risperidone J. Clin. Psychiatry 61 Suppl 12 2000 909 911
12. B. Green Focus on olanzapine Curr. Med. Res. Opin. 15 Suppl 2 1999 79 85
13. M. Hamilton A rating scale for depression J. Neurol. Neurosurg. Psychiat. 23 1960 56
14. M.D. Jibson, and R. Tandon Treatment of acute psychotic episodes J.G. Csernansky Schizophrenia. A New Guide for Clinicians 2002 Marcel Dekker Inc New York 107 139
15. S.R. Kay, A. Fiszbein, and L.A. Opler The positive and negative syndrome scale (PANSS) for schizophrenia Schizophr. Bull. 13 1987 261 276
16. J.L. Karangianis, I.C. Dawe, A. Thakur, S. Begin, J. Raskin, and S.M. Roychowdhury Rapid tranquilization with olanzapine in acute psychosis: a case series J. Clin. Psychiatry 62 Suppl 2 2001 12 16
17. B.J. Kinon, S.M. Roychowdhury, D.R. Milton, and A.L. Hill Effective resolution with olanzapine of acute presentation of behavioral agitation and positive psychotic symptoms in schizophrenia J. Clin. Psychiatry 62 Suppl 2 2001 17 21
18. M.C. Mauri, V. Laini, L. Boscati, R. Rudelli, V. Salvi, and R. Orlandi Long-term treatment of chronic schizophrenia with risperidone: a study with plasma levels Eur. Psychiatry 16 2001 57 63
19. E.B. Nelson, E. Rielage, J.A. Welge, and P.E. Keck Jr. An open trial of olanzapine in the treatment of patients with psychotic depression Ann. Clin. Psychiatry 13 Suppl 3 2001 147 151
20. C.B. Nemeroff Dosing the antipsychotic medication olanzapine J. Clin. Psychiatry 58 Suppl 10 1997 45 49
21. J. Overall, and D. Gorham Brief psychiatric rating scale Psychol. Rep. 10 1962 799 812
22. P.J. Perry, T. Sanger, and C. Beasley Olanzapine plasma concentrations and clinical response in acutely ill schizophrenic patients J. Clin. Psychopharmacol. 17 Suppl 6 1997 472 477
23. P.J. Perry, B.C. Lund, T. Sanger, and C. Beasley Olanzapine plasma concentration and clinical response: acute phase results of the North American olanzapine trial J. Clin. Psychopharmacol 21 Suppl 1 2001 14 20
24. V.I. Reus Olanzapine: a novel atypical neuroleptic agent Lancet 349 1997 1264 1265
25. A. Roy, R. Thompson, and S. Kennedy Depression in chronic schizophrenia Br. J. Psychiatry 142 1983 465 470
26. R.M. Simpson, and J.S.W. Angus A rating scale for extrapyramidal side effects Acta Psychiatr. Scand. 212 1970 11 19
27. M.E. Stockton, and K. Rasmussen Electrophysiological effects of olanzapine, a novel atypical antipsychotic, on A9 and A10 dopamine neurons Neuropsychopharmacol 14 Suppl 2 1996 97 105
28. G.D. Tollefson, T.M. Sanger, Y. Lu, and M.E. Thieme Depressive signs and symptoms in schizophrenia: a prospective blinded trial of olanzapine and haloperidol Arch. Gen. Psychiatry 55 Suppl 3 1998 250 258
29. X. Xiberas, J.L. Martinot, L. Mallet, E. Artiges, C. Loc'H, and B. Maziere Extrastriatal and striatal D2 dopamine receptor blockade with haloperidol or new antipsychotic drugs in patients with schizophrenia Br. J. Psychiatry 179 2001 503 508
30. X.Y. Zhang, D.F. Zhou, L.J. Cao, P.Y. Zhang, G.Y. Wu, and Y.C. Shen Risperidone vs haloperidol in the treatment of acute exacerbations of chronic inpatients with schizophrenia: a randomized double-blind study Int. Clin. Psychopharmacol 16 Suppl 6 2001 325 330